Weaker control of the electrical properties of cerebellar granule cells by tonically active GABA receptors in the Ts65Dn mouse model of Down’s syndrome by unknown
Szemes et al. Molecular Brain 2013, 6:33
http://www.molecularbrain.com/content/6/1/33RESEARCH Open AccessWeaker control of the electrical properties of
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Background: Down’s syndrome (DS) is caused by triplication of all or part of human chromosome 21 and is
characterized by a decrease in the overall size of the brain. One of the brain regions most affected is the
cerebellum, in which the number of granule cells (GCs) is markedly decreased. GCs process sensory information
entering the cerebellum via mossy fibres and pass it on to Purkinje cells and inhibitory interneurons. How GCs
transform incoming signals depends on their input–output relationship, which is adjusted by tonically active GABAA
receptor channels.
Results: We report that in the Ts65Dn mouse model of DS, in which cerebellar volume and GC number are
decreased as in DS, the tonic GABAA receptor current in GCs is smaller than in wild-type mice and is less effective
in moderating input resistance and raising the minimum current required for action potential firing. We also find
that tonically active GABAA receptors curb the height and broaden the width of action potentials in wild-type GCs
but not in Ts65Dn GCs. Single-cell real-time quantitative PCR reveals that these electrical differences are
accompanied by decreased expression of the gene encoding the GABAA receptor β3 subunit but not genes coding
for some of the other GABAA receptor subunits expressed in GCs (α1, α6, β2 and δ).
Conclusions: Weaker moderation of excitability and action potential waveform in GCs of the Ts65Dn mouse by
tonically active GABAA receptors is likely to contribute to atypical transfer of information through the cerebellum.
Similar changes may occur in DS.
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Down’s syndrome (DS) occurs in different populations in
1 in 450 to 2200 live births [1]. It is caused by the presence
of a third copy of all or part of human chromosome 21
(trisomy Hsa21; OMIM ID: 190685)[2], which results
in a range of neurological, behavioural and physical
phenotypes that vary in occurrence and expressivity
between individuals [3]. Characteristics that all individuals
with DS display include a smaller brain, a pronounced* Correspondence: M.M.Usowicz@bris.ac.uk
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reproduction in any medium, provided the ordecrease in neuron number and distorted neuronal
morphology in the cerebellum, hippocampus and cerebral
cortex [4]. They also show impaired learning, memory
and language, delays in the acquisition of motor skills,
poor fine motor skills, altered balance and gait, and
unclear speech [4,5]. These changes in brain structure and
function are accompanied by altered expression of genes
on the triplicated Hsa21 as well as on non-trisomic
chromosomes [2,3,6]. How information processing in
the DS brain is affected to produce the cognitive and
motor deficits is incompletely understood [7]. Recent
studies in mouse models of DS have made progress in
delineating the modifications in hippocampal synapticl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in specific types of memory [8-19]. In comparison,
there have been surprisingly few electrophysiological
investigations of cerebellar function in mouse models
of DS [20,21].
The cerebellum is a key brain structure in the control
of movement. The altered gait, posture, stride length,
speech production, acquisition of motor skills and quality
of fine motor skills observed in DS implicate cerebellar
dysfunction [4,5]. This inference is supported by the finding
that in individuals with DS, the volume of the cerebellum
and the density of cerebellar GCs are reduced by one third
and one quarter respectively, through impaired proliferation
of precursor cells [22-28]. Increasing evidence suggests
that the cerebellum also plays a role in various cognitive
functions [29,30] and that cerebellar dysfunction may
contribute to some of the cognitive deficits in DS [5]. As
GCs process signals transmitted to the cerebellum by
mossy fibres and transmit them to Purkinje cells (PCs) and
inhibitory interneurons [31], changes in their number,
intrinsic electrical properties or synaptic transmission
are likely to distort cerebellar processing.
Postnatal maturation of cerebellar GCs in rodents
entails increased expression of specific GABAA receptor
(GABAAR) subunits and the development of a tonic
current generated by repeated opening of extrasynaptic
GABAAR channels [32-35]. Inhibition of the tonic current
with a competitive GABAAR antagonist demonstrates that
it is caused by the activation of GABAARs by ambient
GABA [32,33,35-37]. The tonic current dampens GC
excitability through shunting inhibition and so modulates
information flow through the cerebellar cortex [33,35,37].
In this study, we made whole-cell patch-clamp recordings
of GCs in the Ts65Dn mouse model of DS to determine
whether the properties of the tonically active GABAAR
channels are modified. We assessed whether their impact
on the electrical properties of GCs is altered, as this could
contribute to the increased excitability and changed action
potential (AP) waveform observed previously in Ts65Dn
GCs [21]. We also investigated whether expression of
GABAAR subunit genes is modified in Ts65Dn GCs, by
means of reverse transcription and real-time quantitative
PCR (qPCR) of single GCs extracted from slices of cerebel-
lum. The Ts65Dn mouse is the most widely investigated
model of DS and is generated by triplication of a region of
mouse chromosome 16 (Mmu16), which makes it trisomic
for approximately half of the orthologous protein-coding
genes and a subset of non-protein coding RNAs located
on the long arm of Hsa21 [17,28,38]. The Ts65Dn mouse
replicates the drop in GC number and density that typifies
DS [26,39,40]. It also shows a decrease in the number of
cerebellar PCs and displays morphological abnormalities
in PC axons [26,39], changes that may be indicative of
alterations in DS [28]. The structural changes in theTs65Dn cerebellum are accompanied by variable changes
in cerebellar expression of genes located in the triplicated
region of Mmu16 and on non-trisomic chromosomes
[41,42].
We describe previously unknown properties of the tonic
current and profile gene expression levels for the major
GABAAR subunits (α1, α6, β2, β3, γ2 and δ) expressed in
wild-type GCs. Our recordings indicate that in the Ts65Dn
mouse model of DS, the control of the electrical properties
of cerebellar GCs by tonically active GABAARs is
weaker. Single-cell qPCR analyses demonstrate a decrease
in expression of the GABAAR β3 subunit gene in Ts65Dn
GCs, but not of most of the other GABAAR subunit genes
investigated. These differences are likely to affect informa-
tion flow through the Ts65Dn cerebellum.
Results
To investigate if the properties of tonically active GABAARs
in cerebellar GCs are altered in the Ts65Dn mouse model
of DS, we made whole-cell patch-clamp recordings
from GCs of mature Ts65Dn animals and their euploid
(wild-type) littermates, aged between postnatal day (P)
40 and P60. We used 10 μM SR95531, a competitive
antagonist at GABAARs, to inhibit GABAARs activated by
ambient GABA. This is expected to block all GABAARs
activated by ambient GABA because 10 μM SR95531
reduces currents evoked by exogenous 10 μM GABA in
P7-20 rat GCs by more than 99% [36]. Furthermore, the
concentration of GABA surrounding GCs is estimated to
be less than 200 nM in P21-40 wild-type rats [43] and
more than 80% of the tonic current in these cells is
inhibited by 200 nM SR95531 [43]. In previous studies, 10
μM SR95531 has been used to inhibit tonic currents or
tonic inhibition in P35-45 rodent GCs under respectively
voltage-clamp or current-clamp [35,44]. We also compared
expression of genes encoding GABAAR subunits by means
of single-cell qPCR in P42-69 GCs. The data presented
were obtained from slices derived from 68 Ts65Dn mice
and 95 wild-type mice.
Tonic GABAAR-mediated current-density is reduced in
Ts65Dn GCs
Application of SR95531 (10 μM) to cells in voltage-clamp
(held at −70 mV with a pipette containing a high Cl− con-
centration; chloride reversal potential, ECl, ~0 mV) caused
a positive shift in mean current and a decrease in the
amplitude of current fluctuations (variance) in both
wild-type and Ts65Dn GCs (Figure 1A), indicating that
GABAAR channels are continuously, or tonically, opening
in both cell-types. However, the tonic GABAAR current-
density (current divided by cell input capacitance in order
to correct for variation in cell surface area) was signifi-
cantly lower in Ts65Dn than in wild-type GCs (Figure 1B)
(median and quartile values, wild-type, 10.6 pA/pF
Figure 1 (See legend on next page.)
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Figure 1 Tonic GABAAR-mediated current-density is reduced in Ts65Dn cerebellar GCs. (A) Current recordings from a wild-type GC (WT,
filled circle) and a Ts65Dn GC (filled triangle) held at −70 mV, before and during application of SR95531 (10 μM, horizontal bar), with a pipette
containing a high Cl− concentration (ECl ~0 mV). Current amplitudes have been normalised by input capacitance. Dashed lines indicate mean
current remaining after block of GABAARs with SR95531. Asterisks indicate phasic currents. (B) Cumulative distribution of tonic GABAAR-mediated
current-densities in mature wild-type (n = 54) and Ts65Dn (n = 38) GCs at a holding potential of −70 mV. Dashed lines point to median values
(*p = 0.0192, Mann–Whitney U test). (C) Plots of the variance of the SR-sensitive tonic current against the mean of the SR-sensitive tonic current at
a holding potential of −70 mV in wild-type (circles) and Ts65Dn (triangles) GCs. Each point represents a different cell. The line on each plot is
drawn through the origin with the same slope of −1.39 pA, which corresponds to the single-channel current, since linear-regression lines fitted to
both sets of data did not differ (slope, p = 0.1475; intercept, p = 0.5354, ANCOVA). (D) Plots of current-density (mean ± SEM) against membrane
potential, expressed relative to values at −70 mV in wild-type (n = 5, circles) and Ts65Dn (n = 5, triangles) cells. Solid lines are fitted
sigmoidal curves.
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equivalent to chord conductances of 172 pS/pF and 97
pS/pF). The reduced tonic current-density did not reflect
smaller current flow through individual channels, as there
was no difference between wild-type and Ts65Dn GCs in
the mean single-channel current amplitude, calculated
as the slope of plots of current variance against current
mean [45], for whole-cell currents inhibited by SR95531
(Figure 1C, −1.39 pA at −70 mV; corresponds to a mean
unitary chord conductance of ~23 pS).
We compared the amplitudes of whole-cell tonic currents
inhibited by SR95531 at different membrane potentials in
some cells, in order to determine if there was a difference
in voltage-dependence of the tonic GABAAR current, as
such a difference could potentially contribute to different
electrical properties of wild-type and Ts65Dn GCs [46].
Figure 1D shows that the dependence of current-density
on voltage was non-linear in both wild-type and Ts65Dn
GCs; alterations in membrane potential below ~−40 mV
caused smaller changes in current-density than changes in
membrane potential above ~−40 mV. The slope conduct-
ance (calculated from plots of absolute current-density
against voltage) increased from 23 ± 14 pS/pF at −100 mV
to 283 ± 98 pS/pF at −10 mV in wild-type GCs (n = 5),
and from 16 ± 8 pS/pF at −100 mV to 216 ± 112 pS/pF
at −10 mV in Ts65Dn GCs (n = 5). Therefore, the tonic
GABAAR current showed outward rectification in both
wild-type and Ts65Dn GCs.
During postnatal development of wild-type cerebellar
GCs, spontaneously-occurring discrete phasic postsynaptic
GABAergic currents decrease in size and frequency, while
the tonic GABAergic current appears at ~ P7 and increases
in magnitude, so that in mature GCs most of the spontan-
eous GABAAR-mediated charge transfer occurs via tonically
active GABAARs [32,33,37]. We found that phasic post-
synaptic currents that were identified as GABAAR-mediated
by their sensitivity to SR95531 also occur at low frequency
in Ts65Dn GCs (Figure 1A; median and quartile values,
wild-type 0.28 Hz (0.12, 0.75), n = 67; Ts65Dn, 0.50 Hz
(0.12, 1.01), n = 47; p = 0.1577, Mann Whitney U test) and
that there was no change in their mean amplitude (median
and quartile values, wild-type, -29.2 pA (−22.7, -35.78),n = 59; Ts65Dn, -26.9 pA (−21.2, -37.3), n = 41; p = 0.8835 )
or decay time course (median and quartile values of
weighted decay time constant, wild-type, 7.8 ms (4.4, 10.9);
Ts65Dn, 5.9 ms (4.5, 8.0); p = 0.1095, Mann Whitney
U test). They carried a minor percentage of the total
charge transferred by spontaneously active GABAARs,
which did not differ from that in wild-type GCs (median
and quartile values, wild-type, 3.3% (1.8, 5.0); Ts65Dn,
3.9% (2.0, 6.7), p = 0.2068, Mann Whitney U test).
Unchanged relative contributions of δ and α6 subunits to
GABAARs mediating tonic currents in Ts65Dn GCs
The lower tonic current-density in Ts65Dn GCs could
potentially reflect altered subunit composition of the
underlying GABAARs, as subunit composition is a key
determinant of the probability of channel opening and
the extent and speed of receptor desensitisation upon
activation by GABA [47]. In wild-type GCs, the tonic
current develops postnatally [32,33] in parallel with in-
creasing expression of δ and α6 subunits in extrasynaptic
GABAARs [34,35]. These receptors have high affinity for
GABA and are continually activated by submicromolar
ambient GABA [48]. We investigated if the contribution
of δ or α6 subunits to extrasynaptic receptors was modified
in Ts65Dn GCs, by testing the effects of subunit-selective
drugs on the tonic current blocked by SR95531. Figure 2A
and 2B show that application of the agonist THIP
(gaboxadol), at a δ-selective concentration of 300 nM [49],
enhanced the current in both wild-type and Ts65Dn GCs.
There was no difference in the magnitude of the effect
(Figure 2C). Figure 2D - F show that furosemide, at a
concentration (100 μM) at which it is selective for the
α6–containing GABAARs in GCs [50,51], inhibited the
tonic current by a similar degree in wild-type and Ts65Dn
GCs. Furosemide also binds to α4-containing GABAARs
but with lower affinity [52] and α4-receptors are absent
from cerebellar GCs [53]. The changes in the size of the
current produced by THIP or furosemide were accom-
panied by proportionate changes in variance, as the
drugs did not alter the linear relationship between
SR95531-sensitive variance and mean current (Figure 3).
This indicates that there were no differences in mean
Figure 2 Unchanged contributions of δ or α6 containing GABAARs to the tonic current in Ts65Dn GCs. (A) Extracts of continuous current
recordings from a wild-type GC (WT, filled circle) and a Ts65Dn GC (filled triangle) held at −70 mV under three conditions: before drug application
(control), in the presence of the δ-selective agonist, THIP (300 nM, dashed horizontal bar) and in THIP (300 nM) plus SR95531 (10 μM, white
horizontal bar). Current amplitude is normalised by cell capacitance. Dashed lines: current remaining after block of GABAARs with SR95531. The
tonic GABAAR-current, measured as the difference between currents in the presence and absence of SR95531, was enhanced by THIP. The
increase was associated with an increase in noise. (B) Summary of tonic GABAAR current-densities in the absence (con.) and presence of THIP in
individual wild-type (*p < 0.0001, Student’s paired t test) and Ts65Dn (*p < 0.0001, Student’s paired t test) GCs. (C) Box plot of current-densities in
THIP expressed relative to control values (dashed line). The enhancement by THIP was not different in wild-type and Ts65Dn cells (*p = 0.9625,
Mann–Whitney U test). (D) Recordings arranged as in A, showing a decrease in tonic current and noise caused by the α6-selective antagonist,
furosemide (100 μM, dashed horizontal bars). Control recordings were made in the presence of DMSO (horizontal lines) at a concentration (0.1%)
equal to that present during the application of furosemide. (E). Tonic GABAAR current-densities in the absence (con.) and presence of furosemide
(fur.) in wild-type (*p = 0.0005, Mann Whitney U test) and Ts65Dn (*p = 0.0007, Student’s paired t test) GCs. (F) Box plot of current-densities in
furosemide relative to control values (dashed line). The fractional inhibition by furosemide was not different in wild-type and Ts65Dn cells
(*p = 0.7520, Mann–Whitney U test).
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resistant tonically active GABAARs in Ts65Dn and wild-
type GCs. These pharmacological investigations show that
the relative contributions of δ and α6 subunit-containing
GABAARs to the tonic current and the unitary conduc-
tances of these receptors do not differ between wild-type
and Ts65Dn GCs.
GABAAR subunit mRNAs in wild-type and Ts65Dn GCs
To test the possibility that the lower tonic current-density
in Ts65Dn GCs was associated with weaker expression of
GABAAR genes, real-time qPCR was used to quantify
GABAAR subunit transcripts in individual granule cells.
Single-cell mRNA was reverse-transcribed into cDNA andcDNAs encoding δ, α6, β2 and β3 subunits were quanti-
fied with real-time PCR, as these encode the extrasynaptic
GABAARs mediating the tonic current in mature wild-type
GCs [35,37,43,54-57]. We also measured cDNAs encoding
GABAAR α1 and γ2 subunits, which together with β2 and
β3 subunits form synaptic GABAARs that mediate phasic
currents when transiently activated [54,55,58], because the
relative synaptic and extrasynaptic distributions of these
subunits are not known for Ts65Dn GCs. Moreover, in
wild-type GCs some extrasynaptic receptors may contain
α1 subunits and some synaptic receptors contain α6
subunits [43,55,59-62]. For this analysis, individual cells
were ‘harvested’ from cerebellar slices into the tip of a
blunt pipette, as illustrated in the sequence of photographs
Figure 3 Enhancement or inhibition of GABAARs with subunit-selective drugs reveals no difference in single-channel current
amplitude. (A and B) Plots of current variance against mean tonic GABAAR currents in wild-type (WT) cells in the absence (filled circles) and
presence (empty circles) of 300 nM THIP (A), and 100 μM furosemide (B, fur). (C and D) Same as (A and B), but for Ts65Dn GCs (filled and empty
triangles). A single least-squares line is fitted to values in the absence and presence of each drug in each plot, as there were no difference
between the slopes and y-intercepts of lines fitted to values in the absence or presence of each drug in either wild-type or Ts65Dn GCs (p > 0.05
for all comparisons, ANCOVA). The slopes and intercepts of the lines shown did not differ between wild-type and Ts65Dn GCs (slope and
intercept: THIP, p = 0.8783 and 0.8539; furosemide, p = 0.936 and 0.06818; ANCOVA). The single-channel current, i, calculated as the slope of each
line, is shown on each plot.
Szemes et al. Molecular Brain 2013, 6:33 Page 6 of 23
http://www.molecularbrain.com/content/6/1/33in Figure 4A. The pipette tip contained a solution that
prevented mRNA degradation during harvesting and
processing of the cell prior to reverse-transcription of
mRNA into cDNA, all of which were carried out immedi-
ately after cell harvesting [63]. The single-cell cDNAs were
stored at −20°C until real-time qPCR, which was performed
under conditions that had been optimised on GABAARcDNAs generated from wild-type mouse cerebellum
(see methods for more details). Only one subunit cDNA
was measured per cell.
Figure 4B summarises the percentages of GCs in which
expression of a gene encoding one of six GABAAR
subunits was detected. Considering firstly wild-type GCs,
Figure 4B reports wide diversity in the proportions of cells
Figure 4 Comparison of GABAAR subunit gene expression in wild-type and Ts65Dn GCs by single-cell real-time PCR. (A) Harvesting of a
GC into a glass pipette. Calibration bar (5 μm) applies to all panels. 1: pipette tip (containing RNA-protecting solution) touching a chosen cell
within a cerebellar slice; 2: suction draws the cell into the pipette. The pipette is raised away from the slice (out of focus) so as to minimise entry
of contaminating material; 3: complete cell in the tip, prior to ejection. (B) Percentages of wild-type (empty bars) and Ts65Dn (filled bars) GCs in
which cDNAs encoding different GABAAR subunits (α6, α1, β2, δ, β3 and γ2) were detected. Numbers of cells are shown on the bars. The various
cDNAs were detected with dissimilar frequencies in both wild-type (χ2(5, n = 226) = 52.73, p < 0.0001) and Ts65Dn (χ2(5, n = 174) = 65.83, p <
0.0001) GCs. The frequency with which each subunit cDNA was detected did not differ between wild-type and Ts65Dn (Fisher’s exact test, p >
0.2020 for all comparisons). (C) Box plots of numbers of cDNA copies calculated for cDNA-positive GCs (log10 scale). The numbers were not
uniform in wild-type (p < 0.0001 Kruskal Wallis test) or Ts65Dn (p < 0.0001 Kruskal Wallis test) GCs but followed the approximate order:
α6≥ α1≥ β2 > δ ≈ β3 ≈ γ2 in both (Dunn’s multiple comparison test p < 0.001 or < 0.01). Copy numbers for α6, α1, β2, and δ cDNA were not
different between wild-type and Ts65Dn (p > 0.2800 for all comparisons, Mann Whitney U test), the number of β3 cDNAs was reduced in Ts65Dn
(*p = 0.0125, Mann Whitney U test), and the number of Ts65Dn GCs in which γ2 cDNAs were detected was too small for statistical comparison.
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(α6, α1 and β2, 86 - 93% cells; δ, ~59% cells; β3, ~42% cells;
γ2, ~35% cells). This denotes disparity in transcription
dynamics of GABAAR genes, as lower detection rates
mirror higher percentages of cells without transcripts at
the time of cell sampling. The disparity was also present
in Ts65Dn GCs and the detection frequencies for α6,
α1, β2, δ and β3 cDNAs in these cells were the same as
in wild-type GCs (Figure 4B). Therefore, there were no
major alterations to transcription dynamics of α6, α1,
β2, δ and β3 subunit genes in Ts65Dn GCs, such as a
complete shut down or a several-fold augmentation of
transcriptional activity. However, γ2 cDNAs were detectedin only half the percentage of Ts65Dn GCs (17%) as in
wild-type GCs (35%), although this difference was not
statistically different (Fisher’s exact test, p = 0.202), possibly
because of the relatively small number of Ts65Dn GCs
examined for the expression of γ2 mRNA.
The numbers of cDNA copies in the cDNA-positive
cells (determined from standard curves, see methods) are
summarised in Figure 4C. As expected from the stochastic
nature and bursting characteristics of gene transcription
[63,64], the values are widely and non-normally distrib-
uted. Figure 4C shows marked variation in the numbers of
cDNAs encoding different subunits, which parallels the
variation in the percentages of cDNA-positive cells shown
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expression can be roughly approximated in wild-type GCs
by the sequence α6 ≥ α1 ≥ β2 > δ ≈ β3 ≈ γ2. The α6, α1,
β2 and δ cDNA copy numbers were not different between
wild-type and Ts65Dn GCs, but the β3 cDNA copy
number was reduced in Ts65Dn GCs. In addition, the
number of γ2 cDNAs appeared to be reduced, but the
low number of γ2-positive Ts65Dn GCs precluded a
statistical analysis (Figure 4C). These single-cell qPCR
data indicate that reduced β3 mRNA expression accom-
panies the reduced tonic current-density in Ts65Dn GCs.
More work is required to confirm the suggested decrease
in γ2 mRNA expression.
Weaker influence of tonic GABAAR conductance on input
resistance of Ts65Dn GCs
Previous studies have established that a tonic GABAAR
current dampens the excitability of mature cerebellar
GCs because it lowers cell input resistance, which results
in smaller changes in voltage in response to current input
[35,37]. This shunting inhibition raises rheobase (the mini-
mum current input required to initiate firing of APs)
[33,35,37]. Notably, moderation of GC input resistance by
tonically active GABAARs is not accompanied by clear
moderation of the resting membrane potential at P18-22
[33] or P30-62 [35,65]. To investigate if shunting inhibition
is altered in Ts65Dn GCs, in which we recorded a smaller
tonic GABAAR current-density in voltage-clamp, we made
whole-cell current-clamp recordings before and during
block of GABAARs with 10 μM SR95531. The composition
of the pipette solution was similar to that previously used
in current-clamp recordings of wild-type cerebellar GCs
[44,66,67]. It established an ECl (~−69 mV) that was more
positive than the mean resting potential (~− 80 mV) of
wild-type and Ts65Dn GCs [21], in keeping with the dif-
ference between the resting potential and the equilibrium
potential for GABAAR currents in wild-type GCs mea-
sured with the non-invasive perforated patch technique
[33,65]. As our voltage-clamp recordings indicated that
the charge carried by the tonic current is far in excess of
that carried by phasic currents in Ts65Dn GCs as well
as in wild-type GCs, the predominant effect of the
application of SR95531 on both types of cells in current-
clamp is block of tonic inhibition rather than block of
phasic inhibition [35,44,67].
Recordings of voltage-changes evoked by current in-
jections showed that before block of tonically active
GABAARs, subthreshold voltage–current relationships
were non-linear in both types of cells (Figure 5A - C), but
depolarising currents caused greater changes in voltage
in Ts65Dn GCs at potentials above resting potential
(Figure 5C). Therefore, input resistance changed with
voltage in both cell-types but Ts65Dn GCs had higher
input resistance at potentials approaching the voltagethreshold for AP firing, as reported previously [21]. This
difference is clearer in plots of mean input resistance
against membrane potential (Figure 5D), derived from
the mean voltage–current relationship in Figure 5C.
Resting membrane potentials did not differ (Figure 1B,
wild-type, −80.21 ± 0.4 mV, n = 24; Ts65Dn, −79.76 ± 0.7
mV, n = 13; p = 0.5137, Student’s unpaired t-test). By
contrast, after block of tonically active GABAARs with
SR95531, the subthreshold voltage–current relationships
in wild-type and Ts65Dn GCs were indistinguishable
(Figure 5A - C). Furthermore, they were much steeper
indicating that in SR95531 the input resistance was
markedly elevated in both cell-types (Figure 5D). In
addition, the voltage-dependence of input resistance was
weaker (Figure 5D). These changes induced by SR95531
were not accompanied by a change in resting membrane
potential in either type of cell (Figure 5C; wild-type:
control, −80.21 ± 0.4 mV, SR95531, −80.87 ± 0.8 mV,
n = 24, p = 0.3563 Student’s paired t-test; Ts65Dn: con-
trol, −79.96 ± 0.7 mV, SR95531, −79.67 ± 1.0 mV, n = 13;
p = 0.9047 Student’s paired t-test). Our finding that the
impact of the tonic inhibition was weaker on the current–
voltage relationship of the Ts65Dn GCs while its lack of
effect on the resting potential was unaltered, lends further
support to other observations that the predominant effect
of tonically active GABAARs in mature GCs is shunting
inhibition rather than alteration of membrane potential
[33,35,37]. The lack of a clear effect on the resting potential
is thought to reflect the small magnitude of the outward
driving force on the Cl− ions [33,65].
The transformations of the subthreshold voltage–current
relationships revealed that the tonic GABAAR conductance
lowers input resistance in a voltage-dependent manner in
both wild-type and Ts65Dn GCs, but this decrease was
weaker in Ts65Dn GCs at potentials approaching the
voltage-threshold for AP firing. The vertical differences
between the curves in Figure 5D show that this effect
accounts for a mean decrease of ~1.6 GΩ at −85 mV
and ~1.1 GΩ at −75 mV in wild-type GCs, and ~1.7 GΩ
at −85 mV and ~0.7 GΩ at −75 mV in Ts65Dn GCs.
Elimination of the difference between the subthreshold
voltage–current relationships of wild-type and Ts65Dn
GCs in SR95531 (Figure 5C) demonstrates that the
higher input resistance of Ts65Dn GCs at membrane
potentials approaching AP threshold under control
conditions (Figure 5D) is due to weaker moderation of
input resistance by the tonic GABAAR conductance.
This is consistent with the smaller tonic current-density
recorded in Ts65Dn GCs in voltage-clamp.
Weaker inhibition of Ts65Dn GC excitability by tonic
activation of GABAARs
In agreement with previous studies of wild-type GCs
[35,37,67], the increase in input resistance caused by
Figure 5 (See legend on next page.)
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Figure 5 Moderation of input resistance by tonic activation of GABAARs is weaker in Ts65Dn GCs. (A) Superimposed traces of voltage-
recordings during constant current injections (from −10 pA to action potential threshold in +2 pA increments) from a wild-type GC before
(filled circle) and after inhibition of tonically-activate GABAARs with 10 μM SR95531 (empty circle). Current values normalised by input capacitance
are also indicated. (B) Same as (A), but for a Ts65Dn GC (filled and empty triangles). (C) Subthreshold voltage–current relationships (mean ± SEM)
for mature wild-type and Ts65Dn GCs before (control) and after application of SR95531 (WT, n = 24 – 14; Ts65Dn, n = 13 – 8). Dotted lines denote
resting membrane potential. Solid lines are fitted sigmoidal curves. In control, the relationships diverged for current injections greater than +2 pA
(*f1,27 = 5.6, p = 0.025, two-way repeated measures ANOVA). In SR95531, the relationships were indistinguishable (the same sigmoidal curve is
fitted to both sets of data points as an F-test did not reveal differences in the parameters of curves fitted to each data set, F(4,8) = 1.094,
p = 0.4214). (D) Plots of input resistance against membrane potential in control and in the presence of SR95531, obtained by differentiating fitted
lines in (C).
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a decrease in rheobase (minimum current input required
to trigger AP firing) in wild-type GCs. This is illustrated
by voltage recordings in Figure 5A and plots summarising
rheobase values in Figure 6A. In Ts65Dn GCs, block of
GABAARs also reduced rheobase (Figure 5B and 6A), but
the decrease was smaller (Figure 6B), in parallel with the
smaller increase in input resistance near AP threshold
(Figure 5D). Furthermore, after block of GABAARs, there
was no difference between the rheobase of wild-type and
Ts65Dn GCs (median and quartile values, wild-type, 1.9
(1.6, 3.4) pA/pF, n = 24; Ts65Dn, 2.4 (1.6, 3.1) pA/pF,
n = 13, p = 0.8056, Mann Whitney U test), whereas
before the application of SR95531, rheobase was lower
in Ts65Dn GCs (wild-type, 5.0 (4.1, 6.5) pA/pF, n = 24;
Ts65Dn, 3.8 (3.3, 5) pA/pF, n = 13, p = 0.0211, Mann
Whitney U test)[21]. The decrease in rheobase upon
application of SR95531 was not accompanied by a
change in the sensitivity of cell firing to changes in
suprathreshold current input in either wild-type or Ts65Dn
mice (Figure 6C). It was also not accompanied by changes
in latency to first AP at rheobase (wild-type, p = 0.3716,
Student’s paired t test; n = 24; Ts65Dn, p = 0.2922, Student’s
paired t test; n = 13), which did not differ between wild-
type and Ts65Dn before (p = 0.9700, Student’s unpaired
t test) or after (p = 0.1358, Student’s unpaired t test)
application of SR95531. In summary, our finding that
rheobase was lower in Ts65Dn than in wild-type GCs
before but not after block of GABAARs, demonstrates
that the tonic conductance exerts weaker inhibition of
cell-excitability in Ts65Dn GCs.
Weaker control of action potential waveform in Ts65Dn
GCs by tonic activation of GABAARs
Under control conditions, the height of APs (measured
between peak and afterhyperpolarisation) was greater in
Ts65Dn GCs than in wild-type GCs (Figure 7A and B)
[21]. We investigated the possibility that this was also
due to a weaker influence of the tonically active
GABAARs in Ts65Dn GCs, although previous studies in
wild-type GCs had not reported a moderating effect on
AP waveform [35,37]. We found that block of GABAARs
with SR95531 increased AP height in wild-type (by ~4%)but not Ts65Dn GCs, thus eliminating the difference in
height present in control conditions (Figure 7A and B).
SR95531 also hyperpolarised AP voltage threshold, as
illustrated by the vertical displacement of the super-
imposed traces in Figure 7A (from −47.93 ± 0.63 mV
to −52.34 ± 0.66 mV in 24 wild-type GCs, p < 0.0001;
from −46.51 ± 0.69 mV to −50.13 ± 0.92 mV in 13 Ts65Dn
GCs, p = 0.0001, Student’s paired t tests). This negative
shift was similar in magnitude in wild-type and Ts65Dn
GCs (wild-type, 4.41 ± 0.64 mV; Ts65Dn GCs, 3.62 ± 0.49
mV, p = 0.4040, Student’s unpaired t test) unlike the differ-
ential effect of SR95531 on AP height. Vertical alignment
of APs recorded before and during application of SR95531
on their voltage-thresholds (Figure 7C) revealed that the
increase in AP height in wild-type GCs was mainly due to
an increase in peak amplitude relative to threshold, which
was unchanged in Ts65Dn GCs (Figure 7D). In addition,
there was a small decrease in afterhyperpolarisation relative
to threshold (wild-type, 1.3 ± 0.7 mV, n = 24; Ts65Dn GCs,
1.5 ± 0.5 mV, n = 13) that did not differ between cell-type
(Figure 7D, p = 0.8514, Student’s unpaired t test). As well
as increasing AP height in wild-type GCs, block of
GABAARs accelerated maximum rates of rise and fall
of APs (Figure 7E and F) by a similar percentage
(~16 and ~18%, p = 0.7156, Student’s unpaired t test).
This resulted in a shortening of AP duration (Figure 7G)
and elimination of the difference in AP width between
wild-type and Ts65Dn GCs under control conditions
(control: p = 0.0473, n = 24; SR95531: p = 0.9334, n = 13,
Student’s unpaired t test). In contrast, the kinetics and
duration of APs in Ts65Dn GCs were not significantly
altered in SR95531 (Figure 7E - G). Therefore, tonically
active GABAARs modulate AP waveform in wild-type
GCs but have a much weaker effect on AP waveform in
Ts65Dn GCs.
Our finding that the changes in AP waveform in wild-
type GCs upon inhibition of GABAARs occurred in the
absence of a change in mean resting potential does not
support the possibility that the increase in amplitude
and narrowing of the APs reflects removal of inactivation of
voltage-gated ion channels by reversal of GABAAR-induced
membrane depolarisation. However, it was possible that
a relationship between a change in AP waveform and
Figure 6 Tonic activation of GABAARs has a weaker impact on excitability of Ts65Dn cerebellar granule cells. (A) Values of
rheobase (minimum current-density required to initiate AP firing) before and during block of GABAARs with SR95531, in wild-type
(*p < 0.0001, Wilcoxon matched pairs test; n = 24) and Ts65Dn (*p = 0.0005, Wilcoxon matched pairs test; n = 13) GCs. Overlapping points
are horizontally offset. (B) Box plots comparing the change in rheobase induced by the application of SR95531 in wild-type and Ts65Dn
GCs (*p = 0.0145, Mann Whitney U test). (C) Dependence of AP frequency (mean ± SEM) on magnitude of injected current-density above
rheobase in the absence (filled symbols) and presence (empty symbols) of SR95531, in wild-type and Ts65Dn GCs (WT, n = 24 – 12;
Ts65Dn, n = 13 – 5).
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average values, which masked variation in the effect of
SR95531 in different cells between a small decrease, no
effect or a small increase in resting potential or APamplitude. Therefore, we plotted the change in AP
amplitude against the change in resting potential for
individual wild-type cells. This revealed a weak correl-
ation (r(22) = −0.317, p = 0.1494), suggesting that a
Figure 7 Tonically-active GABAARs modify AP shape more strongly in wild-type GCs than in Ts65Dn GCs. (A) Superimposed APs (centred
on their peak) from a wild-type (filled circle) and a Ts65Dn (filled triangle) GC before (thin line, control) and during inhibition of GABAARs with
10 μM SR95531 (thick line). Each trace is the average of 3 APs recorded at rheobase. (B) Under control conditions (con) AP height (dashed arrow,
mean ± SEM) was greater in Ts65Dn GCs (*p = 0.0360, Student’s unpaired t test). SR95531 (SR) increased AP amplitude in wild-type (*p = 0.0125,
Student’s paired t test; n = 24) but not in Ts65Dn GCs (p = 0.6553, Student’s paired t test; n = 13); in the presence of SR95531 AP heights in wild-
type and Ts65Dn GCs were no longer different (*p = 0.2754, Student’s unpaired t test). (C) Traces in (A) vertically aligned on their threshold so as
to aid shape comparison. (D) AP peak and AHP (afterhyperpolarisation) measured from threshold (mean ± SEM) before (con) and during
application of SR95531 (SR). SR95531 increased the peak in wild-type (*p = 0.0167, Student’s t paired test) but not in Ts65Dn GCs (p = 0.7074,
Student’s paired t test). SR95531 caused small decreases in AHP (wild-type, p = 0.0584; Ts65Dn, *p = 0.0107; Student’s paired t tests). (E) Maximum
rate of AP rise (mean ± SEM) was speeded up by SR95531 in wild-type (*p = 0.00003, Student’s paired t test) but not Ts65Dn GCs (p = 0.1577,
Student’s paired t test). (F) As in (E), but comparing maximum rates of fall (WT, *p = 0.0013; Ts65Dn, *p = 0.3116; Student’s paired t tests).
(G) SR95531 shortened AP width in wild-type (*p = 0.0001, Student’s paired t test) but not in Ts65Dn GCs (p = 0.0132, Student’s paired t test).
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factor underlying the increase and narrowing of APs caused
by inhibition of tonically active GABAARs.
Discussion
Our study demonstrates that in wild-type cerebellar
GCs, tonic activation of GABAARs moderates input
resistance in a voltage-dependent manner and modifies the
waveform of APs. Our study also profiles wide variation in
expression of genes encoding α1, α6, δ, γ2, β2 and β3
subunits of GABAARs in wild-type GCs. In GCs of the
Ts65Dn mouse model of DS, tonically active GABAARs
exert a weaker control over input resistance and AP wave-
form, which results in increased excitability and the firing
of APs with increased amplitude. These differences in
electrical properties are accompanied by decreased
transcription of the Gabrb3 gene encoding the GABAAR β3
subunit, in the absence of changes in expression of
genes encoding GABAAR α1, α6, δ or β2 subunits, while a
suggested difference in γ2 gene expression deserves
further exploration.
Tonically active GABAARs moderate input resistance and
action potential waveform
We confirmed that tonically active GABAARs control
input resistance and rheobase in mature wild-type GCs
[35,37,67] without a detectable effect on resting membrane
potential, as reported previously for mature GCs [35,65],
but also uncovered previously unknown characteristics.
We find that the tonic GABAAR conductance is not
constant, as sometimes assumed, but increases in size at
voltages approaching threshold, like the outwardly rectifying
tonic GABAAR current in hippocampal CA1 pyramidal
neurons [46]. We also find that tonic activation of
GABAARs slows the kinetics and curbs the height of
APs in wild-type GCs. In contrast, tonic activation of
GABAARs has minimal effect on AP shape in Ts65Dn
GCs, and APs in wild-type and Ts65Dn GCs are the
same height after block of GABAARs. Our finding that
SR95531 had almost no impact on AP waveform in
Ts65Dn GCs counteracts the possibility that the effects
of SR95531 on APs in wild-type GCs reflect off-target
binding to the ion channels that generate the AP (unless
these are different in wild-type and Ts65Dn GCs).
Further evidence that the effects of SR95531 are mediated
by inhibition of GABAARs, without effects on other
channels, is the previously reported lack of an effect of
SR95531 on input resistance and rheobase in cerebellar
GCs lacking extrasynaptic GABAARs [35].
It is not clear how tonic activation of GABAARs modifies
AP waveform in wild-type GCs. In hippocampal mossy
fibre boutons, GABAARs tonically activated by ambient
GABA also reduce AP amplitude and make APs wider
[68]. These changes are thought to reflect enhancedinactivation of voltage-gated sodium channels secondary
to depolarisation of the membrane by tonically active
GABAARs [68]. However, such a mechanism seems
unlikely to account for the effects of tonically active
GABAARs on APs in wild-type GCs, because the increase
in AP amplitude and decrease in AP duration upon inhib-
ition of GABAARs with SR95531 were not accompanied
by detectable changes in membrane potential or in the
duration of the subthreshold depolarisation preceding
the AP (which might change the fraction of inactivated
voltage-gated channels). An alternative explanation is
that the outwardly-rectifying tonic conductance generated
by the repeatedly opening GABAAR channels is able to
shunt the currents that generate the AP. Shunting of APs
by a GABAAR conductance has been previously observed
in primary afferents [69] and in the soma of dentate
granule neurons [70], and has been demonstrated in a
modelling study [71].
Decreased expression of Gabrb3 in Ts65Dn GCs
Our results indicate that the smaller tonic GABAAR
current in GCs of Ts65Dn mice does not arise because
of a reduced single-channel conductance or differences
in the relative contributions of α6 and δ subunits, which
are important determinants of GABA potency and receptor
desensitisation [43,47,56,72,73]. A contributing factor to
the smaller current might be the decreased transcription
of Gabrb3 that we detected with single cell qPCR. This
could result in fewer receptors at the cell surface because
β3 subunits control trafficking of GABAARs [74]. This
possibility has yet to be explored experimentally by
measurement of cell surface expression of the receptors
or currents evoked by exogenous GABA. Further contribut-
ing factors to the smaller tonic current in Ts65Dn GCs may
be changes in ambient GABA concentration. A decrease
would result in the activation of fewer channels while an
increase might also reduce the mean number of channels
open if it enhances desensitisation. The GABA concentra-
tion is reported to be reduced in foetal DS brains [75] but
unchanged in post-mortem samples of cerebellum from
adults with DS [76].
Decreased expression of GABAAR β3 mRNA or β2/3
protein has been detected before in adult Ts65Dn mouse
brain, in the fascia dentata of Ts65Dn hippocampus at 3
months but not at 8 months, in DS brain cells (cultured
neural progentior cells derived from foetal DS cortex)
but not in the hippocampus of Ts65Dn mice at P15
[13,77-79]. Why transcription of Gabrb3 might be down-
regulated is unclear. This cannot be due to a change in
gene dosage because Gabrb3 is located on Mmu7 and not
on the partially trisomic Mmu16. Likewise, in humans,
Gabrb3 is located on Hsa15 and not on Hsa21, which is
trisomic in DS. It is possible that in DS, disomic Gabrb3 is
modified by overexpressed trisomic microRNAs (miRNAs)
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The trisomic region of Mmu16 in Ts65Dn mice harbours
two of the miRNAs located on Hsa21, mir-155 and mir-802,
[2,80,81,83,84] and these are overexpressed in Ts65Dn
hippocampus and prefrontal cortex [80]. However, they are
not predicted to target human or mouse Gabrb3 mRNAs
[85-87]. Gabrb3 expression might also be modified by
disomic miRNAs or transcription factors, whose expres-
sion is altered by trisomic miRNAs or transcription factors
or whose properties are postranslationally modified by
interactions with trisomic proteins [2,6,78,80-82]. A further
possibility is that downregulation of Gabrb3 expression
in Ts65Dn GCs is secondary to changes in the ambient
concentration of GABA.
GABAergic transmission is altered in Ts65Dn mice
The smaller tonic GABAAR current and its weaker effects
in Ts65Dn GCs are in contrast with augmented GABAergic
inhibition in dentate granule cells and CA1 pyramidal
neurons of Ts65Dn hippocampus [8,10-18,88], which like
the cerebellum is markedly reduced in volume and
cell-number in individuals with DS and in Ts65Dn mice
[4,5,17,28,89]. The enhanced inhibition impairs long term
potentiation (LTP) and learning and memory in Ts65Dn
mice and is suggested to be due to up regulation of fast
or slow phasic transmission by, respectively, GABAA
or GABAB receptors [8-18,88]. The increase in GABAAR-
mediated synaptic transmission is cell and age specific. It
does not occur in all subtypes of CA1 neurons or at all
ages [13,90], whereas hippocampal CA3 pyramidal
neurons of P13-16 Ts65Dn mice show a reduction in
inhibitory GABAAR-mediated synaptic input and no
impairment of LTP [91]. The molecular basis of the
enhanced GABABR-mediated inhibition is cell-type
specific over expression of the GABAB effector, GIRK2,
which occurs because the encoding Kcnj6 gene is
triplicated in Ts65Dn mice, as it is in individuals with
DS [13,14,92]. In adult Ts65Dn cerebellum, GIRK2
expression is elevated in unipolar brush cells rather
than GCs [93]. Our study did not detect differences in
the frequency or time course of spontaneous phasic
GABAAR-mediated postsynaptic currents in cerebellar
GCs, but evoked phasic GABAAR-mediated transmission
has yet to be investigated.
The possibility that increased inhibition in Ts65Dn
CA1 hippocampal neurons is due not only to changes in
phasic inhibition but also to upregulation of tonic GABAAR
currents has not been addressed directly, by measuring the
tonic GABAAR currents that are known to be expressed in
these and other types of hippocampal cells [46,56,94-97].
Indirect evidence for their augmentation in the Ts65Dn
mouse model of DS is alleviation of cognitive deficits by a
selective inverse agonist (α5IA) [98] or a negative allosteric
modulator (RO4938581) [99] of α5-containing GABAARs,which is the class of GABAAR that generates a tonic
current in hippocampal CA1 and CA3 pyramidal neurons
[96,97]. It has also been suggested that the beneficial
effects of chronic treatment with α5IA involve changes in
gene expression [100].
Significance of weaker control of electrical properties in
Ts65Dn cerebellar GCs by tonically active GABAARs
The weaker moderation of excitability and AP waveform
by tonically active GABAARs in Ts65Dn GCs predicts
that detection and transfer of incoming signals from
mossy fibres and hence sensory information processing
by the cerebellum is not the same as in wild-type mice.
In vivo recordings from GCs of young rats (P18-22)
show that block of tonically active GABAARs increases
firing of GCs in response to incoming sensory signals.
The increase is moderate relative to the greater increase
in spontaneous firing [44,67] and hence sensory signals
are less likely to be discriminated from the enhanced
background activity, resulting in impaired fidelity of
sensory transmission through the GC layer. However, it is
uncertain how closely these observations predict the effect
of tonically active GABAARs on adult GCs, because the
electrical properties of P18-22 and mature GCs are not
identical [21,35,44,65,67]. Information transfer by Ts65Dn
GCs could also be affected by the change in AP shape, as
it is becoming apparent that neural information is
encoded not only in the frequency and pattern of firing
but also in the shape of APs [101]. For example, the
altered AP waveform could distort the time course of
glutamate release from GC axons on to Purkinje cell
dendrites and inhibitory interneurons. If the changes in
GC excitability and AP waveform also occur in DS,
reinstatement of the tonic current to an optimal level with
agonists or positive allosteric modulators selective for the
underlying α6-containing GABAARs may help correct
cerebellar dysfunction. Such drugs should not exacerbate
the cognitive deficits in Ts65Dn mice arising from increased
inhibition in the hippocampus because the hippocampus,
like most brain structures external to the cerebellum, is
devoid of α6 GABAARs [53,57]. On the other hand, if the
decrease in tonic current is a compensatory mechanism
for the fall in GC number that aims to maintain informa-
tion flow through the cerebellum, drugs that enhance the
function of α6-containing GABAARs may exacerbate
cerebellar dysfunction in DS, since augmentation of tonic
inhibition above an optimum level can also impair transfer
of sensory transmission through the GC layer of the
cerebellar cortex [44].
Drugs that inhibit GABAAR function have been suggested
as potential treatments for the improvement of mental
capacity in DS because they counteract excess inhibition
in the hippocampus [5,11,15-17,38,88,98,99]. Since we find
that the tonic GABAAR current is decreased in cerebellar
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target GABAARs in the hippocampus without affecting
extrasynaptic GABAARs in cerebellar GCs. Examples of
such drugs are the α5-selective compounds α5IA [98] and
RO4938581 [99], because α5-containing GABAARs are
highly expressed in the hippocampus but not the cerebel-
lum [53,57]. In contrast, the interaction of the antagonist
pentylenetetrazole with a broader range of GABAARs may
explain why it not only improves memory function in
Ts65Dn mice but may also exacerbate their impaired
ability to maintain equilibrium, a behaviour that requires
the proper operation of the cerebellum [88].
The effects of upregulating the tonic current in cerebel-
lar GCs with drugs selective for α6- containing GABAARs,
could be investigated on cognitive deficits in Ts65Dn mice
with standard tests of learning and memory [17,38]. Evalu-
ation of the potential effects of these drugs on speech and
language, both of which rely on the correct operation of the
cerebellum and are markedly affected in DS [5,30,102,103],
might be possible in Ts65Dn mice through the analysis of
ultrasonic vocalisations [104], the development of which is
delayed in Ts65Dn mice [105]. However, appraisal of the
potential of these drugs to improve motor dysfunction in
DS by testing their effects on Ts65Dn mice would not be
straightforward, because despite the marked drop in
cerebellar volume and GC number and density, and the
weaker influence of the tonic-active GABAARs on elec-
trical properties of GCs described in the current study,
changes in sensorimotor performance of Ts65Dn mice
have not been consistently observed. Alterations in equi-
librium, motor coordination, locomotor activity or gait
dynamics have been detected in some studies or in a
subset of tests [88,105-111] but not in other studies
[26,112-114]. It is not known if the tonic GABAAR current
is altered in cerebellar GCs of other mouse models of DS.
In summary, we report that GCs in the hypogranular
cerebellum of the Ts65Dn mouse model of DS have a
smaller tonic GABAAR current and weaker expression of
the GABAAR β3 subunit-gene than GCs in wild-type ani-
mals. The smaller tonic current contributes to increased
excitability and the firing of APs with increase amplitude
and faster kinetics. Similar changes may accompany the




Mice were generated by crossing female B6EiC3Sn a/A-
Ts(1716)65Dn (Ts65Dn) mice, carrying a partial trisomy
of chromosome 16 [115], with C57BL/6JEi × C3H/HeSnJ
(B6EiC3Sn) F1 males, at the University of Bristol, in
accordance with the United Kingdom Animals (Scientific
Procedures) Act 1986 and with the University of Bristol
Ethical Review Group. Parental generations of all threemice strains were obtained from The Jackson Laboratory
(Bar Harbor, Maine, USA). To distinguish trisomic Ts65Dn
animals from euploid animals (wild-type, littermates of the
trisomic animals), quantitative real-time polymerase chain
reaction of tail-tip genomic DNA [116] was used to
measure expression of the App gene (present in three
copies in Ts65Dn and two copies in wild-type animals)
relative to expression of the Apob gene (present in two
copies in both Ts65Dn and wild-type animals; The Jackson
Laboratory Protocols) [117].
Cerebellar slices
Parasagittal slices of cerebellar vermis (200 μm) were pre-
pared from 50 male Ts65Dn mice and 70 male wild-type
mice (littermates of Ts65Dn mice) aged P40-60, on a Leica
VT1000S vibrating microtome (Leica Microsystems,
Nussloch, Germany). Animals were culled in accordance
with the United Kingdom Animals (Scientific Procedures)
Act 1986 and the University of Bristol Ethical Review
Group. Slices were cut in ice-cold sucrose-based solution
(in mM: 248 sucrose, 1.3 MgSO4, 5 KCl, 2.4 CaCl2, 1.2
KH2PO4, 26 NaHCO3, 10 D-glucose, pH 7.4, bubbled with
95% O2/5% CO2) and stored in standard Krebs-Henseleit
solution (in mM: 124 NaCl, 1.3 MgSO4, 5 KCl, 2.4 CaCl2,
1.2 KH2PO4, 26 NaHCO3, 10 D-glucose, pH 7.4, bubbled
with 95% O2/5% CO2) prior to patch-clamp recording or
harvesting of cells.
Patch-clamp recording and analysis
Individual slices were viewed on a Zeiss FS Axioskop
microscope (Carl Zeiss Ltd., Welwyn Garden City, UK).
Patch-clamp recordings were made with pipettes (thick-
walled borosilicate glass, coated with Sylgard 184, fire-
polished) and an Axopatch 200A or 200B amplifier
(Axon Instruments, Union City, CA), from slices superfused
with standard Krebs-Henseleit solution (~1.5 ml/min)
at ~23°C, as described previously [32] and in keeping
with previous patch-clamp studies of granule cells at a
similar temperature [35,118-121]. Pipettes were filled
with, in mM: 135 CsCl, 10 HEPES, 2 MgATP, 10 EGTA
(pH 7.2 with TEA-OH) for voltage-clamp recording, or
126 KCH3SO3, 4 KCl, 10 HEPES, 4 MgATP, 5 EGTA, 4
NaCl, 0.5 CaCl2 (pH 7.2 with K-OH) for current-clamp
recording, and had resistances of 3.5 – 10 MΩ. Input
capacitance measurements of cells recorded in voltage-
clamp were taken from amplifier settings used to cancel
current transients generated by 5 mV jumps, as in
several previous patch-clamp studies of granule cells
[32,35,36,119]. Median and quartile values: wild-type,
1.9 (1.5, 2.3) pF, n = 58; Ts65Dn, 2.7 (2.0, 3.2) pF, n = 38.
When cells were recorded in current-clamp, input
capacitance was calculated from the time-constant of a
single exponential function fitted to the voltage deflection
generated by a negative current injection (−10 or −8 pA)
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pF, n = 43; Ts65Dn, 3.7 (3.0, 4.0), n = 25. GCs of all ages
are known to behave as single electrical compartments
and the measured input capacitance encompasses capaci-
tances of the soma and dendrites [119].
Current recordings were low-pass filtered by the filter
in the Axopatch 200A amplifier (10 kHz, 4 pole Bessel)
and then passed through a second filter (2 kHz, 8 pole
low-pass Bessel filter, Frequency Devices, Haverhill, MA,
USA), or they were filtered by the amplifier-filter alone
(2 or 5 kHz), before being digitised on-line at 10 or 25
kHz with a Cambridge Electronic Design (CED) power
1401 A/D interface using Spike2 software (v. 5.13) (CED,
Cambridge, UK). Voltage recordings were low-pass filtered
(4 pole Bessel filter in the Axopatch 200B amplifier) at 10
kHz and acquired at 62.5 kHz with Signal (v. 3 or 4) or
Spike2 software. They were analysed with CED Signal or
Spike2 software and with Origin software v.6 or 7
(Microcal, Northampton, MA).
Currents were recorded before and after blockade of
GABAARs by SR95531 (10 μM) at a holding potential
of −70 mV. In a few cells, tonic current–voltage relation-
ships were measured by holding the membrane potential
at different values between −100 mV and 0 mV for 2–4 s
before and during the application of SR95531. The ampli-
tude and variance of the tonic current generated by the
activation of GABAARs by ambient GABA were calculated
as the difference between the mean amplitude and variance
around the mean of ~5 s periods of digitised data recorded
before and during application of SR95531. Sections of
data without discrete synaptic currents were chosen for
measurement, but if these were rare, multiple periods
lacking discrete events adding up to 5 s were measured.
Slope conductances at different potentials were calculated
from sigmoidal curves fitted to plots of mean current-
density against voltage. Plots of SR95531-sensitive variance
against SR95531-sensitive mean current measured in many
cells were used to derive the mean unitary current of the
GABAARs [45]. Whole-cell and single-channel chord
conductances were calculated using the reversal potentials
of the mean whole-cell current–voltage curves in wild-type
and Ts65Dn GCs. The relative charge transfer during tonic
and phasic synaptic currents was calculated from 20–30 s
periods of digitised data recorded before and during the
application of SR99531 [123]. The decay time course of the
phasic currents was determined by fitting a double expo-
nential function or, rarely, a single exponential function to
average currents constructed for each recording by aligning
the phasic currents on their rising phase (CED Spike 2
software). The zero time point was defined as the time at
the peak of the current. The weighted mean time constant
was calculated as A1.τ1 + A2.τ2, where A1 and A2 are the
fractional amplitudes of the fast and slow components, and
τ1 and τ2 are the time constants of the two components.Membrane potentials recorded in current-clamp were
corrected for a calculated junction potential of 8.8 mV.
AP parameters were measured for the first three APs
elicited near rheobase (current injection threshold) using
Signal or a supplementary Signal script that generated
‘phase-plane plots’ for the measurement of voltage thresh-
old and maximum rates of rise and fall (Steven Clifford,
CED), and then averaged. AP height was measured between
the peak and the afterhyperpolarisation [124]. Increments
in the size of currents injected result in unequal increments
in current-density (pA/pF) in different cells, because of cell-
to-cell variation in input capacitance. To enable averaging
of plots of voltage or AP frequency against current-density,
the plot for each cell was interpolated using equally-spaced
points (0.5 or 0.1 pA/pF interval) and interpolated values
were averaged.
Stock solutions were made of the following drugs:
SR95531 (10 mM in filtered Milli-Q water, Tocris Bio-
science, Bristol, UK or Ascent Scientific, Bristol, UK),
THIP (30 mM in filtered Milli-Q water, Tocris Bioscience),
furosemide (100 or 300 mM in 100% DMSO, Sigma).
They were stored as aliquots at −20°C and added to the
external solution when required. The effects of the drugs
THIP and furosemide were measured 11–14 mins after
application.
Single-cell reverse transcription real-time PCR
GABAAR subunit mRNAs were quantified in individual
GCs harvested from cerebellar slices prepared from 18
male Ts65Dn mice and 25 male euploid littermates
(wild-type). These animals were similar in age (P42 – 69)
to the animals from which slices were prepared for patch-
clamp recording (P40-60). The procedures described below
are based on methods developed previously [63]. The study
reports absolute quantification of mRNAs in individual
cells derived from comparison of real-time data to standard
curves, rather than relative expression normalised by
expression levels of reference genes.
Cell harvesting
On the day of cell harvesting, pipettes were pulled from
thin-walled borosilicate glass capillaries (Harvard Appar-
atus, Kent, UK) and fire-polished to a tip size of 1.5 – 3 μm.
These had been made RNase-free by one rinse with 0.5 M
NaOH, two rinses with absolute ethanol, three or four
rinses with sterile ultra-pure Elgastat water (0.2 μm filtered)
and baking at 160°C for 2 × 4 hours. In order to harvest
a single cell, a pipette was filled with 4 μl of ‘RNA-
protecting solution’, which contained 15 U RNasinW
Plus or RNasinW ribonuclease inhibitor (Promega,
N2515 or N2615, Southampton, UK) and 25 mM DTT
(Clontech, accompanies PowerScript reverse transcript-
ase 639501, Saint-Germain-en-Laye, France). The two
components were combined on each day of harvesting
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lution under positive pressure and moved towards the
cell of interest. Once the tip was at the cell, the positive
pressure was released and gentle suction was applied to
the pipette via a mouthpiece and a length of tubing, so
as to draw the cell into the pipette. Suction was stopped
as soon as the majority of the cell was in the tip. This
procedure was observed on a monitor using AxioVision
software and an AxioCam HRm camera attached to the
Zeiss FS Axioskop microscope (Carl Zeiss Ltd.). Much ef-
fort was put into optimising the size of the pipette tips, by
iteratively changing puller settings and fire-polishing. (If the
tips were too large, it was difficult to prevent the cell
and bath solution from rushing far up the pipette. If they
were too small, the cell stuck to the outside of the pipette
tip.) After the cell was just inside the pipette, the outside
of the pipette was inspected for any extraneous tissue that
may have become attached. Such material was blown away
with a second pipette containing extracellular solution. If
the unwanted material could not be removed, the pipette
containing the harvested cell was discarded. We found
that it was important to maintain the positive pressure on
the pipette until it touched the cell so as to prevent entry
of bath solution into the pipette.
Reverse transcription
In order to release mRNA from the cell, the pipette
containing the harvested-cell and 4 μl of ‘RNA-protecting
solution’ (see above) was quickly positioned inside a
thin-walled 0.2 ml PCR tube (sometimes a 0.5 ml tube)
containing 2 μl of a solution that included the detergent
Nonidet P40 (0.2%, Roche 11754599001, Mannheim,
Germany), plus some reagents necessary for reverse
transcription (10 mM Tris–HCl pH 8, Ambion Life
Technologies, AM9855G, Paisley UK; 25 μM random
hexamers, Roche 11034731001; 2.5 mM of each dNTP,
Bioline 39025 or 39028, London, UK). The tip was
broken by pushing it against the inside wall of the tube,
and the pipette contents were expelled into the mixture
by applying pressure (12 psi for 100 ms) via a filtered
(0.2 μm) tube. This procedure was observed under a
dissecting microscope. The tube was placed in a water
bath at 65°C for 5 min and then on ice for 5 min.
Additional reagents necessary for reverse transcription
were then added. Their final concentrations in a total
volume of 10 μl were 10 mM DTT (Clontech, comes
with PowerScript reverse transcriptase), 2 U RNasinW or
RNasinW Plus (Promega, N2515 or N2615), 1× first
strand buffer (Clontech, accompanies PowerScript reverse
transcriptase). (Taking into account the reagents present
in the harvesting-pipette solution, the solution into which
the cell was ejected and the added reagents, the final
concentrations of the various components in a total
volume of 10 μl were 20 mM DTT, 0.04% Nonidet P40,5 μM random hexamers, 0.5 mM of each dNTP, 2 mM
Tris–HCl, 17U RnasinW or RNasinW Plus). Reverse tran-
scriptase was then added (PowerScript, 0.5 or 0.75 μl,
Clontech 639501, concentration undisclosed) and the
tube was incubated at 42°C overnight in a thermal cy-
cler (usually a PTC-200 DNA engine, Bio-Rad, Hemel
Hempstead, UK). The reaction was stopped at 75°C for
15 minutes. The tube containing the single-cell cDNA
was stored at −20°C.
Single-cell real-time quantitative PCR
For amplification of cDNA encoding a single type of
GABAAR subunit in a single harvested granule cell, the
mix containing single-cell cDNA was combined with a
pair of forward and reverse primers (final concentrations,
400 nM, except for the reverse primer for the Gabrg2
gene, which was 300 nM) (OliGoldW purified on a
reverse-phase cartridge, Eurogentec, Southampton, UK),
25 μl of a SYBR-Green I mix (QuantiTect SYBR Green
PCR kit, Qiagen 204143, Crawley, UK) and water to bring
the final reaction volume up to 50 μl. The SYBR-Green I
mix contained HotStarTaq DNA polymerase, PCR buffer
(composed of Tris–HCl, KCl, (NH4)2SO4, MgCl2, pH8.7),
a dNTP mix, SYBR Green I and the passive reference dye
ROX (concentrations undisclosed by supplier except for
MgCl2). The final concentration of MgCl2 was 2.5 mM.
The forward and reverse primers were designed to be
located in different exons and to amplify multiple splice
variants of a gene of interest, as indicated in Table 1, with
the aid of BLAST, Primer-BLAST and Beacon Designer
software (version 4, PREMIER Biosoft, Palo Alto, CA,
USA). To activate the HotStarTaq DNA polymerase, the
tube was incubated on a Stratagene Mx3000P qPCR
machine at 95°C for 15 min (Agilent Technologies, Stock-
port, UK). PCR was executed by cycling the temperature
50 times according to the sequence: 95°C, 15 s; 60 or
61°C, 60 s; 72°C 30 s. This was followed by generation
of a melt curve between 55°C and 95°C to confirm the
amplification of a single product and to check for the
occurrence of primer dimers. cDNA encoding only one
type of GABAAR subunit was measured per cell.
The PCR reaction volume was relatively large (50 μl)
so as to dilute components of the reverse-transcription
mixture and thus minimise any inhibition they might
have on the efficiency of the PCR assay. Reactions were
carried out in strips or plates of 0.2 ml tubes sealed with
optically-clear caps (Stratagene 410088; 401425; Fisher
Scientific FB68750, Loughborough, UK). In order to min-
imise variation and allow comparison between wild-type
and Ts65Dn cells, PCR of cDNA encoding a single type of
GABAAR subunit was carried out simultaneously on cells
from both wild-type and Ts65Dn mice. For each assay on
a batch of cells, the PCR reaction and melt analysis were
also concurrently carried out on a non-template control
Table 1 Primers for quantification of expression of GABAAR subunit genes in granule cells with real-time PCR
Gene NCBI mRNA reference sequence(s) Primers (5′-3′) Position Amplicon length (bp)
Gabra1 NM_010250.4 F: GAGCAGAAGTTGTCTATGAGTGG 1349, exon 7 164
R: GTGGAAGTGAGTCGTCATAACC 1512, exon 8
Gabra6 NM_001099641.1 F: CTACTCTGAAAATGTCAGTCGGATTC 364, exon 2 123
(variant 1) R: CCAAAGCTGGTCACATAGATGTCT 486, exon 3
NM_008068.2 364, exon 2 123
(variant 2) 486, exon 3
Gabrb2 NM_008070.3 F: AGGGGCTACTTTGGGATTTGG 446, exon 2 108
R: TCTGTCCACCGTCTCTTTAACC 553, exon 3
Gabrb3 NM_008071.3 F: TTGCGGAGAAGACAGCCAAG 1128, exon 9 100
(variant 1) R: TGAACATCCATCGGTGCTAATAGG 1227, exon 10
NM_001038701.1 1060, exon 9 100
(variant 2) 1159, exon 10
Gabrd NM_008072.2 F: GCCAGCATTGACCATATCTCAG 324, exon 3 169
R: CATTCACGATGAAGGTGTCAGG 492, exon 4
Gabrg2 NM_008073.2 F: CTTACATTCCCTGCACACTCATC 1181, exon 7 140
(variant 1) R: AGATTTTCTGGCTATGGTGCTT 1320, exon 8
NM_177408.5 822, exon 7 140
(variant 2) 961, exon 8
Szemes et al. Molecular Brain 2013, 6:33 Page 18 of 23
http://www.molecularbrain.com/content/6/1/33(containing water instead of a cell sample) and on a serial-
dilution of known numbers of PCR products in duplicate
(9 concentrations expressed as a number of single-stranded
copies, spanning ~3.5 orders of magnitude), from which a
gene-specific standard curve was generated (Table 2). The
lowest points on the curves were 4, 6, 9 or 15 single-
stranded copies. Copy numbers of GABAAR subunit tran-
scripts in each cell were determined as the number of
single-stranded copies relative to the regression lines fitted
to the standard curves. Detection of a GABAAR subunit
cDNA in a cell was defined as an estimated copy number
of more than 2.
Standard curves for quantification of single-cell copy
numbers
For construction of standard curves that were run in par-
allel with cell samples, PCR products were serially-diluted
in 1 mM Tris–HCl pH 8 and 1.25 ng/μl sonicated DNA
from salmon testes (included as a DNA carrier, incubated
before use at 95°C for 10 min to inactivate potential
DNases, Sigma D9156). Each reaction was carried out in
duplicate in a volume of 50 μl, containing the same con-
centrations of primers and SYBR-Green mix as the reac-
tions on single-cell cDNA. So as to mimic the environment
in which single-cell cDNA was amplified, the reaction mix
was supplemented with reagents used during cell harvesting
and reverse transcription (2 μl of the nucleotide/detergent
solution (final concentration: 0.4 mM Tris–HCl, 0.1 mM
each dNTP, 0.008% Nonidet P40), 2 μl of 5× first strand
buffer (final concentration: 0.2×) and 4 mM DTT). Aconstant threshold fluorescence value was selected from
the exponential phase of PCR and the cycle number at
this threshold (the quantification cycle, Cq) was plotted
against the log of the number of copies in each serial
dilution. The parameters of the standard curves are
shown in Table 2.
Generation of PCR products for standard curves
PCR products used to generate gene-specific standard
curves that were run alongside cell-samples, were made by
conventional PCR of cDNA that we reverse-transcribed
from RNA isolated from wild-type mouse cerebellar vermis
(see below), using the forward and reverse primers listed in
Table 1. PCR reactions were carried out in a volume of 50
μl, which contained 0.5 U Biotaq Red DNA polymerase
(Bioline 21038), NH4 buffer (composed of 67 mM Tris–
HCl (pH 8.7), 16 mM (NH4)2SO4, 10 mM KCl), 2 mM
MgCl2 (accompanies Biotaq), 0.2 mM each dNTP; 200 nM
each primer (Eurogentec); 625 pg or 10 ng mouse cere-
bellar cDNA. The generation of a single product of
expected size was verified by agarose gel electrophor-
esis. Each amplicon was extracted from an agarose gel
(Qiaex II, Qiagen 20021) and the concentration of the
product recovered was quantified by running an aliquot
on an agarose gel, measuring the intensity of the band
(Kodak EDAS 290 imaging system, Carestream, CT) and
comparing this intensity to the intensities of quantitative
ladders run on the same gel (EZ Load precision Molecular
Mass ruler, Bio-Rad 170–8356, Hemel Hempstead, UK).
Concentrations were converted to numbers of moles
Table 2 Properties of standard curves and lack of signal in no-template controls
Gene Slope Y-intercept Efficiency (%) Regression Cq of no-template controls
Gabra1 −3.21 41.22 105 0.995 48.9 (primer dimer)
(Cq for the lowest unknown concentration was 38.3)
−3.42 41.72 96 0.993 No signal
−3.19 41.57 106 0.999 No signal
−3.30 40.65 101 0.998 No signal
Gabra6 −3.39 41.55 97 0.995 No signal
−3.48 41.59 94 0.987 No signal
−3.45 41.91 95 0.997 No signal
−3.39 41.52 97 0.999 No signal
Gabrb2 −3.22 39.62 104 0.998 No signal
−3.35 39.35 99 0.991 No signal
Gabrb3 −3.44 40.22 95 0.999 No signal
−3.37 40.99 98 0.999 No signal
Gabrd −3.11 40.68 110 0.998 No signal
−3.18 40.44 106 0.999 No signal
−3.33 39.49 100 0.996 No signal
−3.33 39.66 100 0.999 No signal
Gabrg2 −3.28 39.03 102 0.999 No signal
−3.34 39.70 99 0.996 No signal
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biomath/Default.htm) and then to numbers of double-
stranded DNA molecules using the Avogadro constant.
Quantified PCR products were stored at −20°C at two
concentrations (108 and 106 double-stranded copies/μl) in
low-binding 0.5 ml tubes, precoated with 0.1 mg/ml
BSA (New England BioLabs, B9001S) in 10 mM Tris–HCl
(pH 8, Ambion, Life Techonolgies, Paisley, UK) to prevent
binding of the amplicons to the tubes.
Cerebellar cDNA and initial optimisation of real-time PCR
Prior to amplification of single-cell cDNA with SYBR-
Green I, reaction conditions for real-time PCR were
optimised by amplification of adult mouse cerebellar
cDNA that was made and quantified using standard
protocols. Briefly, total RNA was extracted from cerebellar
vermis (frozen in liquid nitrogen immediately upon dissec-
tion and stored at −80°C) of wild-type mice using TRIzolW
Reagent (Invitrogen 15596–026, Life Technologies, Paisley
UK), quantified with the Quant-iT RNA Assay Kit
(Invitrogen Q32852) on the Stratagene Mx3000P machine
and stored at −80°C. The integrity of the RNA was assessed
on a denaturing formaldehyde agarose gel. Samples of
RNA (1 μg) were treated with DNase I (Ambion AM1906)
and reverse-transcribed at 42°C with oligodT primers
(Ambion AM5730G) and Powerscript reverse transcriptase
(Clontech, as above). The cDNA was purified, concentrated
(QIAEX II resin, Qiagen) and quantified at 260 nm
(GeneQuant RNA/DNA calculator (Amersham Biosciences,Little Chalfont, UK). PCR reactions (SYBR-Green I) were
run in triplicate on 5-fold serial dilutions of cerebellar
cDNA covering a range of 128 – 80000 double-stranded
copies. The specificity of the PCR products was verified
with melting curve analysis and agarose gel electrophoresis.
Primer concentrations and the annealing temperature were
adjusted until the PCR efficiency was above 90% and the
coefficient of variation of the replicate Cq values was below
1. The same conditions were then applied to more dilute
serial dilutions of PCR products which were expected to
correspond more closely to numbers of transcripts in indi-
vidual cells (9 dilutions spanning ~3.5 orders of magnitude,
the lowest points on the curves were 4, 6, 9 or 15 single-
stranded copies). The conditions were altered as neces-
sary, before being used in single-cell PCR (see above and
Table 2).
Statistical tests
Statistical tests on electrophysiological data were performed
using Origin (v. 6 or 7), GraphPad Prism (v.4, La Jolla, CA)
or PASW Statistics (v. 18, IBM SPSS, Portsmouth, UK)
and considered significant at p < 0.05. PCR data were
analysed with MxPro (v.3, Stratagene), Origin, GraphPad
Prism, Microsoft Excel and PASW. Differences were
examined using the Student’s paired or unpaired t test
(when normally distributed as assessed by the Shapiro-
Wilk test) or the Mann–Whitney U test (when data
were not normally distributed). Slopes of fitted linear
regression lines were compared using analysis of
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exact tests were used to compare the frequency of
detection of cDNAs in individual cells. Kruskal Wallis
non-parametric ANOVA was used to compare the num-
bers of different cDNAs. Data are summarized as mean ±
standard error of the mean (SEM) or median and quartile
values (in parentheses), with n denoting numbers of cells.
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